Richard Aarnio
richard.aarnio@utu.fi +358 29 450 3840 +358 50 356 2885 Tykistökatu 6 A Turku : 4032 |
- SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes : A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study (2024)
- Diabetes Care
- SV2A PET shows hippocampal synaptic loss in cognitively unimpaired APOE ε4/ε4 homozygotes (2024)
- Alzheimer's and Dementia
- Synaptic density in multiple sclerosis: An in vivo study using [11C]UCB-J-PET imaging (2024)
- Multiple Sclerosis
- [11C]carfentanil PET imaging for studying the peripheral opioid system in vivo: effect of photoperiod on mu-opioid receptor availability in brown adipose tissue (2023)
- European Journal of Nuclear Medicine and Molecular Imaging
- Lower abdominal adipose tissue cannabinoid type 1 receptor availability in young men with overweight (2023)
- Obesity
- Quantification of the purinergic P2X(7) receptor with [C-11]SMW139 improves through correction for brain-penetrating radiometabolites (2023)
- Journal of Cerebral Blood Flow and Metabolism
- ASIC-E4: Interplay of Beta-Amyloid, Synaptic Density and Neuroinflammation in Cognitively Normal Volunteers With Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease - Study Protocol and Baseline Characteristics (2022)
- Frontiers in NeurologyEJNMMI Research
- Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation (2022)
- Novel plasma protein binding analysis method for a PET tracer and its radiometabolites: A case study with [11C]SMW139 to explain the high uptake of radiometabolites in mouse brain2022
- Journal of Pharmaceutical and Biomedical AnalysisInternational Journal of Obesity
- Obesity risk is associated with altered cerebral glucose metabolism and decreased μ-opioid and CB1 receptor availability (2022)



